Table 3.
First Injection (n) | Last Injection (n) | p * | |
---|---|---|---|
Mean onaBoNT-A units | 65.0 ± 31.2 (91) | 78.6 ± 51.1 (91) | 0.002 |
Mean global rating | 3.0 ± 1.3 (91) | 3.2 ± 1.2 (91) | 0.06 |
Mean peak effect | 3.2 ± 1.3 (91) | 3.4 ± 1.1 (91) | 0.18 |
Moderate or marked benefit (score of 3 or 4) | |||
Global rating | 74.7% | 80.2% | - |
Peak effect | 80.2% | 85.7% | - |
Mean latency of response, days | 4.5 ± 4.3 (81) | 3.8 ± 3.0 (78) | 0.10 |
Mean total duration of response, weeks † | 12.7 ± 3.6 (46) | 12.8 ± 2.8 (37) | 0.87 |
OnaBoNT-A = onabotulinumtoxin-A. * p < 0.05 indicating a statistically significant result. † Data not included for patients with persistent response (27 versus 41) or lack of data (18 versus 13) at the time of follow-up after the first and last injection.